3/14/2013

Screening patients at risk for heart failure but without symptoms, and then beginning treatment based on B-type natriuretic peptide levels, reduced the risk of hospitalization for heart failure and left ventricular dysfunction, according to a study from University Hospital in Dublin presented at the American College of Cardiology meeting. Researcher Dr. Kenneth McDonald said the study shows that BNP screening could have "a significant impact on the development of new-onset heart failure."

Related Summaries